New drug to prevent childhood respiratory disease

New drug to prevent childhood respiratory disease

The Food and Drug Administration (FDA) announced Monday approval of a drug to prevent respiratory disease caused by respiratory syncytial virus (RSV) in infants and young children.

The drug, manufactured by Sanofi and AstraZenecal, will help prevent infants or children facing the first circulation of the virus, and also those up to two years of age who remain vulnerable to the disease.

In most of the country, virus circulation is seasonal, typically beginning in the fall and peaking in the winter. The disease is spread from person to person through contact with someone who is infected.

“RSV can cause severe illness in infants and some children, and results in a large number of visits to emergency rooms and doctors’ offices each year,” said John Falrey, director of the FDA’s Office of Infectious Diseases.

“Today’s approval addresses a great need for products that help reduce the impact of RSV on children, families, and the health care system,” he added.

The virus causes an acute respiratory infection in people of all ages, and while most infants and children experience mild, cold-like symptoms, some infants, especially on their first infection, develop illnesses such as pneumonia and bronchitis.

According to the American Academy of Pediatrics, approximately 1-3% of children under 12 months of age in the United States are hospitalized each year due to RSV.

The FDA explained that beyfortus is a monoclonal antibody with activity against RSV.

A dose given by intramuscular injection before or during the start of the virulence season may provide protection during the RSV season.

According to the Centers for Disease Control and Prevention (CDC) 58,000 to 80,000 children under the age of 5 are hospitalized each year due to infection with this virus.

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!